Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Salehjahromi, M, Li, H, Showkatian, E, Saad, M, Qayati, M, Ismail, SM, Sujit, S, Muneer, A, Aminu, M, Hong, L, Han, X, Heeke, S, Cascone, T, Le, X, Vokes, N, Gibbons, DL, Toumazis, I, Ostrin, EJ, Antonoff, MB , Vaporciyan, AA, Jaffray, D, Kay, FU, Carter, B, Wu, CC, Godoy, M, Lee, JJ, Gerber, DE, Heymach, JV, Zhang, J, Wu, J
Corner TP, Tumber A, Salah E, Jabbary M, Nakashima Y, Schnaubelt LI, Basak S, Alshref FM, Brewitz L, Schofield CJ (2025) Derivatives of the clinically used HIF prolyl hydroxylase inhibitor desidustat are efficient inhibitors of human -butyrobetaine hydroxylase
Outcome signal Tissue repair research Evidence cue High-interest recovery profile Decision rhythm Start / Compare / Explore Best-fit signals Choose BPC-157 when these match your goal Frequently researched together Build a peptide stack before checkout Selected stack $1354 Save $167 with stack pricing Save $150 more with subscribe-and-save 3 products 3-month plan ships quarterly 10% stack discount 10% subscribe discount Plan length Pay every 3 months Ships every 3 months Decision timeline What to expect as you compare BPC-157 Timelines vary by goal, dose, baseline health, and consistency
Most people use PT 141 as needed before intimacy
